2019-05-05 10:34:00 Sun ET
technology social safety nets education infrastructure health insurance health care medical care medication vaccine social security pension deposit insurance
Former Vice President Joe Biden enters the next U.S. presidential race with many moderate-to-progressive policy proposals. At the age of 76, Biden stands out the presidential race as the favorite among Democratic voters in the recent polls. Biden enters the fray with a half-century of government experience with senior roles as the former chairman of Senate Foreign Relations Committee and vice president under President Barack Obama. On public finance, Biden cites high health care and energy costs as the primary threats to the economic prosperity of U.S. firms. Addressing these economic issues helps U.S. firms better compete worldwide. In addition, Biden supports better balancing the fiscal budget with deficit reductions. This fiscal policy stance contrasts with big tax cuts under the Trump administration. Biden indicates the essential need for U.S. banks to operate under the 5 key pillars of financial regulation: capital rules, low-leverage limitations, liquidity requirements, macroprudential stress tests, and deposit insurance constraints.
On agriculture, Biden opposes importing non-native species, which inadvertently alter domestic vegetation, compete with native species, introduce new diseases, and interfere with maritime commerce. Biden also supports a $15 minimum wage proposal, higher taxation on capital investment income, no tuition for public college students, and broader infrastructure.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2020-04-17 07:23:00 Friday ET

Clayton Christensen defines and delves into the core dilemma of corporate innovation with sustainable and disruptive advances. Clayton Christensen (2000)
2019-06-21 13:33:00 Friday ET

Amazon and Google face more intense antitrust scrutiny. In recent times, Justice Department and Federal Trade Commission have reached an internal agreement
2023-01-09 10:31:00 Monday ET

Response to USPTO fintech patent protection As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved our U.S. utility patent
2019-11-26 11:30:00 Tuesday ET

AYA Analytica finbuzz podcast channel on YouTube November 2019 In this podcast, we discuss several topical issues as of November 2019: (1) The Trump adm
2018-01-04 07:36:00 Thursday ET

The world now faces an economic inequality crisis with few policy options. Some recent U.S. Federal Reserve data suggest that both income and wealth inequal